Jasper Therapeutics (JSPR) Profit After Tax (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Profit After Tax of -$9.1 million for Q4 2025, up 62.65% year-over-year from -$5.6 million in Q4 2024, and up 51.33% quarter-over-quarter from -$18.7 million in Q3 2025.
Jasper Therapeutics (JSPR) Profit After Tax (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Profit After Tax history runs 6 years deep, the most recent figure standing at -$9.1 million for Q4 2025.
- In Q4 2025, Profit After Tax rose 62.65% year-over-year to -$9.1 million; the TTM figure through Dec 2025 stood at -$75.8 million (down 6.21% YoY), while the FY2025 annual figure was -$75.8 million, down 6.36% from the prior year.
- Profit After Tax for Q4 2025 stood at -$9.1 million, up from -$18.7 million in the prior quarter.
- The five-year high for Profit After Tax was -$2.2 million in Q1 2022, with the low at -$26.7 million in Q2 2025.
- The 5-year median for Profit After Tax is -$14.0 million (2023), against an average of -$13.6 million.
- The sharpest annual moves came in 2021 and 2022: Profit After Tax sank 782.64% in 2021, then soared 77.37% in 2022.
- Jasper Therapeutics' Profit After Tax stood at -$6.2 million in 2021, then plunged by 113.94% to -$13.2 million in 2022, then dropped by 26.02% to -$16.6 million in 2023, then slumped by 46.66% to -$24.4 million in 2024, then soared by 62.65% to -$9.1 million in 2025.
- Business Quant data shows JSPR's Profit After Tax at -$9.1 million in Q4 2025, -$18.7 million in Q3 2025, and -$26.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.10 Mn |
| Sep 30, 2025 | -18.70 Mn |
| Jun 30, 2025 | -26.72 Mn |
| Mar 31, 2025 | -21.24 Mn |
| Dec 31, 2024 | -24.37 Mn |
| Sep 30, 2024 | -18.64 Mn |
| Jun 30, 2024 | -14.60 Mn |
| Mar 31, 2024 | -13.73 Mn |
| Dec 31, 2023 | -16.62 Mn |
| Sep 30, 2023 | -17.54 Mn |
| Jun 30, 2023 | -16.08 Mn |
| Mar 31, 2023 | -14.26 Mn |
| Dec 31, 2022 | -13.19 Mn |
| Sep 30, 2022 | -11.86 Mn |
| Jun 30, 2022 | -10.40 Mn |
| Mar 31, 2022 | -2.21 Mn |
| Dec 31, 2021 | -6.16 Mn |
| Sep 30, 2021 | -3.41 Mn |
| Jun 30, 2021 | -3.41 Mn |
| Mar 31, 2021 | -9.75 Mn |